Download PDF
Thromb Haemost 1997; 77(06): 1068-1072
DOI: 10.1055/s-0038-1656113
Clinical Studies
Schattauer GmbH Stuttgart

Molecular Mechanisms of Mutations in Factor XIII A-subunit Deficiency: In vitro Expression in COS-cells Demonstrates Intracellular Degradation of the Mutant Proteins

Aarno Palotie
1   The Department of Clinical Chemistry, University of Helsinki and the Laboratory Department of Helsinki University Central Hospital, Helsinki, Finland
,
Hanna Mikkola
1   The Department of Clinical Chemistry, University of Helsinki and the Laboratory Department of Helsinki University Central Hospital, Helsinki, Finland
,
Laszlo Muszbek
2   The Department of Clinical Chemistry, University Medical School of Debrecen, Debrecen, Hungary
,
Gizela Haramura
2   The Department of Clinical Chemistry, University Medical School of Debrecen, Debrecen, Hungary
,
Eija Hämäläinen
1   The Department of Clinical Chemistry, University of Helsinki and the Laboratory Department of Helsinki University Central Hospital, Helsinki, Finland
,
Anu Jalanko
3   The Department of Human Molecular Genetics, National Public Health Institute, Helsinki, Finland
› Author Affiliations
Further Information

Publication History

Received 11 October 1996

Accepted after revision 26 February 1997

Publication Date:
12 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Factor XIII deficiency is an autosomal recessive bleeding disorder that is largely caused by various mutations in FXIII A-subunit gene. Characteristically, the patients lack both A-subunit activity and antigen in the circulation. Here we have analysed the consequences of four mis-sense mutations (Met242→Thr, Arg252→Ile, Arg326→Gln, Leu498 to Pro) and one stop mutation (Arg661→Stop) in the FXIII A-subunit gene by expression in COS-cells. After transient transfection each mutant cDNA expressed mRNA at an equal level to the wild type FXIII. However, the mutant polypeptides accumulated in the cells in significantly reduced quantities and demonstrated only very low enzymatic activity. Analysis of immunoprecipitated metabolically labelled polypeptides demonstrated remarkable instability and intracellular degradation of all mutant FXIII proteins. These results verify the deleterious nature of the individual amino acid changes and confirm that protein instability and susceptibility to proteolysis are consequences of the mutations, as predicted from the three-dimensional model of crystallised FXIII A-subunit.

 

  • References

  • 1 Board PG, Losowsky MS, Miloszewski KJ. Factor XIII: inherited and acquired deficiency. Blood Rev 1993; 07: 229-242
    CrossrefPubMedGoogle Scholar
  • 2 Aeschlimann D, Paulsson M. Transglutaminases: protein cross-linking enzymes in tissues and body fluids. Thromb Haemost 1994; 71: 402-415
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 McDonagh J, McDonagh RP, Delage JM, Wagner RJ. Factor XIII in human plasma and platelets. J Clin Invest 1969; 48: 940-946
    CrossrefPubMedGoogle Scholar
  • 4 Muszbek L, Adany R, Szegedi G, Polgar J, Kavai M. Factor XIII of blood coagulation in human monocytes. Thromb Res 1985; 37: 401-410
    CrossrefPubMedGoogle Scholar
  • 5 Poon MC, Russell JA, Low S. etal Hemopoietic origin of factor XIII A subunits in platelets, monocytes, and plasma. Evidence from bone marrow transplantation studies. J Clin Invest 1989; 84: 787-792
    CrossrefPubMedGoogle Scholar
  • 6 Adany R, Antal M. Three different cell types can synthesize factor XIII subunit A in the human liver. Thromb Haemost 1996; 76: 74-79
    PubMedGoogle Scholar
  • 7 Kamura T, Okamura T, Murakawa M. et al Deficiency of coagulation factor XIIIA subunit caused by the dinucleotide deletion at the 5’ end of exon III. J Clin Invest 1992; 90: 315-319
    CrossrefPubMedGoogle Scholar
  • 8 Board P, Coggan M, Miloszewski K. Identification of a point mutation in factor XIIIA subunit deficiency. Blood 1992; 80: 937-941
    PubMedGoogle Scholar
  • 9 Ichinose A, Kaetsu H. Molecular approach to structure-function relationship of human coagulation factor XIII. Methods Enzymol 1993; 222: 36-51
    PubMedGoogle Scholar
  • 10 Standen GR, Bowen DJ. Factor XIII A Bristol 1 detection of a nonsense mutation (Argl71→ stop codon) in factor XIII deficiency. Br J Haematol 1993; 85: 769-772
    CrossrefPubMedGoogle Scholar
  • 11 Mikkola H, Syrjälä M, Rasi V. et al Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 1994; 84: 517-525
    PubMedGoogle Scholar
  • 12 Vreken P, Niessen RWLM, Peters M, Schaap MC, Zuithoff-Rijntjes JG, Sturk A. A poin mutation in an invariant splice acceptor site results in a decreased mRNA level in a patient with severe coagulation factor XIII subunit A deficiency. Thromb Haemost 1995; 74: 584-589
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Coggan M, Baker R, Miloszewski K, Woodfield G, Board P. Mutations causing coagulation factor XIII subunit A deficiency: Characterization of the mutant proteins after expression in yeast. Blood 1995; 85: 2455-2460
    PubMedGoogle Scholar
  • 14 Anwar R, Stewart AD, Miloszewski KJ, Losowsky MS, Markham AF. Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function. Br J Haematol 1995; 91: 728-735
    CrossrefPubMedGoogle Scholar
  • 15 Aslam S, Poon M-C, Yee VC, Bowen DJ, Standen G. Factor XIIIAcalgary: A candidate missense mutation (Leu667Pro) in the beta barrel 2 domain of the factor XIII A-subunit. Br J Hematol 1995; 91: 452
    CrossrefPubMedGoogle Scholar
  • 16 Mikkola H, Yee VC, Syrjälä M. et al Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit. Blood 1996; 87: 141-151
    PubMedGoogle Scholar
  • 17 Mikkola H, Muszbek L, Laiho E. Molecular mechanism of a mild phenotype in factor XIII deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA. Blood 1997; 89: 1279-1287
    PubMedGoogle Scholar
  • 18 Kansadalampai S, Farges-Berth A, Caglayan SH, Board PG. New mutations causing the premature termination of translation in the A subunit gene of coagulation factor XIII. Thromb Haemost 1996; 76: 139-142
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Yee VC, Pedersen LC, le TrongI, Bishop PD, Stenkamp RE, Teller DC. Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. Proc Natl Acad Sci USA 1994; 91: 7296-7300
    CrossrefPubMedGoogle Scholar
  • 20 Ichinose A, Hendrickson LE, Fujikawa K, Davie EW. Amino acid sequence of the a subunit of human factor XIII. Biochemistry 1986; 25: 6900-6909
    CrossrefPubMedGoogle Scholar
  • 21 Stacey A, Schnieke A. SVpoly: a versatile mammalian expression vector. Nucleic Acid Research 1990; 18: 2829
    CrossrefPubMedGoogle Scholar
  • 22 Syvanen AC, Aalto-Setälä K, Harju L, Kontula K, Söderlund H. A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics 1990; 8: 684-692
    CrossrefPubMedGoogle Scholar
  • 23 Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-2770
    CrossrefPubMedGoogle Scholar
  • 24 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467
    CrossrefPubMedGoogle Scholar
  • 25 Sussman DJ, Milman G. Short-term, high-efficiency expression of transfected DNA. Mol Cell Biol 1984; 04: 1641-1643
    CrossrefPubMedGoogle Scholar
  • 26 Jalanko A, Manninen T, Peltonen L. Deletion of the C-terminal end of aspartylglucosaminidase resulting in a lysosomal accumulation disease: evidence for a unique genomic rearrangement. Hum Mol Gen. 1995
    Google Scholar
  • 27 Laemmli T. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
    CrossrefPubMedGoogle Scholar
  • 28 Paunio T, Kangas H, Kalkkinen N, Haltia M, Palo J, Peltonen L. Towards understanding the pathogenic mechanism in gelsolin-related amyloidosis: in vitro expression reveals an abnormal gelsolin fragment. Hum Mol Gen 1994; 03: 2223-2229
    CrossrefPubMedGoogle Scholar
  • 29 Proia RL, D’Azzo A, Neufield EF. Association of alfa -and beta-subunits during biosythesis of beta-hexosaminidase in cultured fibroblasts. J Biol Chem 1984; 259: 3350-3334
    PubMedGoogle Scholar
  • 30 Lorand L, Campbell-Wilkes LK, Cooperstein L. A filter paper assay for transamidating enzymes using radioactive amine substrates. Anal Biochem 1972; 50: 623-631
    CrossrefPubMedGoogle Scholar
  • 31 Urlaub G, Mitchell PJ, Ciudad CJ, Chasin LA. Nonsense mutations in the dihydrofolate reductase gene affect RNA processing. Mol Cell Biol 1989; 09: 2868-2880
    CrossrefPubMedGoogle Scholar
  • 32 Kaetsu H, Hashiguchi T, Foster D, Ichinose A. Expression and release of the a and b subunits for human coagulation factor XIII in baby hamster kidney (BHK) cells. J Biochemistry 1996; 119: 961-969
    CrossrefPubMedGoogle Scholar
  • 33 Castle S, Board PG. Genetic heterogeneity of factor XIII deficiency: First description of unstable A subunits. Br J Haematol 1981; 48: 337
    CrossrefPubMedGoogle Scholar
  • 34 Castle SL, Board PG. Biochemical characterisation of genetically variant and abnormal blood coagulation factor XIII A subunits. Clin Chim Acta 1983; 133: 141-151
    CrossrefPubMedGoogle Scholar
  • 35 Micanovic R, Procyk R, Lin W, Matsueda GR. Role of histidine 373 in the catalytic activity of coagulation factor XIII. J Biol Chem 1994; 269: 9190-9194
    PubMedGoogle Scholar
  • 36 Hettasch JM, Greenberg CS. Analysis of the catalytic activity of human factor XIIIa by site-directed mutagenesis. 1994; 269: 28309-28313
    PubMedGoogle Scholar
  • 37 Lai T-S, Achyuthan KE, Santiago MA, Greenberg CS. Carboxyl-terminal truncation of recombinant factor XIII A-chains. 1994; 269: 24596-24601
    PubMedGoogle Scholar